»
Outcomes associated with the use of medications for opioid use disorder during pregnancy

Outcomes associated with the use of medications for opioid use disorder during pregnancy

The article examines the outcomes of using medications for opioid use disorder (MOUD) during pregnancy, focusing on methadone and buprenorphine. It highlights that while MOUD improves maternal outcomes and reduces risks of relapse, it may also be associated with neonatal opioid withdrawal syndrome, necessitating careful clinical management.

Krans, E. E., Kim, J. Y., Chen, Q., Rothenberger, S. D., James, A. E., 3rd, Kelley, D., & Jarlenski, M. P. (2021). Outcomes associated with the use of medications for opioid use disorder during pregnancy. Addiction (Abingdon, England)116(12), 3504–3514. https://doi.org/10.1111/add.15582